Cholecystokinin and panic disorder - Three unsettled questions

Regulatory Peptides

Volumn 93, Issue 1-3, 2000, Pages 79-83

  Rehfeld, Jens F ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Cholecystokinin; Panic disorder; Panicogenic effect

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ B RECEPTOR; TETRAGASTRIN;

ANXIETY; CEREBROSPINAL FLUID; HUMAN; PANIC; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

AMINO ACID SEQUENCE; ANIMAL; CHOLECYSTOKININ; HUMAN; MOLECULAR SEQUENCE DATA; PANIC DISORDER; RECEPTORS, CHOLECYSTOKININ; SUPPORT, NON-U.S. GOV'T; TETRAGASTRIN;

EID: 0034714886     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(00)00179-8     Document Type: Review

References (58)

1. New peptide in the vertebrate CNS reacting with gastrin antibodies
2. Identification of two related pentapeptides from the brain with potent opiate agonist activity
3. Immunochemical evidence of cholecystokinin-like peptides in the brain
4. Cholecystokinin and its COOH-terminal octapeptide in pig brain
5. Gastrins and cholecystokinins in brain and gut
6. Localization of gastrin to neuro- and adenohypophysis
7. Progastrin and its products in the cerebellum
8. Immunochemical studies on cholecystokinin. II. Distribution and molecular heterogeneity in the central nervous system and small intestine of man and hog
9. Localization and molecular heterogeneity of cholecystokinin in the central and peripheral nervous system
10. Cholecystokinin
11. Neuronal cholecystokinin: one or multiple transmitters?
12. Cholecystokinin and anxiety, an overview
13. Effect of gastrin and its C-terminal tetrapeptide on insulin secretion in man
14. Neural regulation of pancreatic hormone secretion by the C-terminal tetrapeptide of CCK
15. Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neurons
16. Cholecystokinin and panic disorder
17. Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers
18. Cholecystokinin tetrapeptide induces panic attacks in patients with panic disorders
19. Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder
20. Dose ranging study of the effect of CCK-4 in healthy volunteers
21. The panicogenic effects of cholecystokinin tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist in patients with panic disorder
22. Pentagastrin has panic-inducing properties in obsessive compulsive disorder
23. Anxiogenic-like action of caerulein, a CCK-8 receptor agonist, in the mouse: influence of acute and subchronic diazepam treatment
24. Cholecystokinin and anxiety in normal volunteers: an investigation of the anxiogenic properties of pentagastrin and reversal by cholecystokinin receptor subtype B antagonist L-365,260
25. The anxiogenic effects of CCK-4 in monkeys are reduced by CCK-B antagonists, benzodiazepines or adenosine A2 agonists
26. Effects of cholecystokinin tetrapeptide and sulfated cholecystokinin octapeptide in rat models of anxiety
27. Failure of CCK receptor ligands to modify anxiety-related behavioral suppression in an operant conflict paradigm in rats
28. A placebo controlled trial of L-365,260, a CCK-B antagonist, in panic disorder
29. Failure of intravenous pentagastrin challenge to induce panic-like effects in Rhesus monkeys
30. Modulation of memory, reinforcement and anxiety parameters by intra-amygdala injection of cholecystokinin-fragments, Boc-CCK-4 and CCK-8-s
31. The cholecystokinin hypothesis of panic anxiety disorders: a review
32. Biological actions of cholecystokinin
33. Cholecystokinin in anxiety
34. Cholecystokinin and psychiatric disorders
35. CCK in anxiety and cognitive processes
36. Brain circuits in panic disorder
37. Structure-function relationships in the active C-terminal tetrapeptide sequence of gastrin
38. Characterization of procholecystokinin products in the porcine cerebral cortex: evidence of different processing pathways
39. New molecular forms of cholecystokinin. Microsequence analysis of forms previously characterized by chromatographic methods
40. CCK-5, sequence-analysis of a small cholecystokinin from canine brain and intestine
41. Expression cloning and characterization of the canine parietal cell gastrin receptor
42. The human gastrin/cholecystokinin type B receptor gene: alternative splice donor site in exon 4 generates two variant mRNAs
43. A dose-ranging study of the behavioral and cardiovascular effects of CCK-tetrapeptide in panic disorder
44. Comparative distribution of cholecystokinin and other neuropeptides: why is this peptide different from all other peptides
45. Gastrin and cholecystokinin in human cerebrospinal fluid: immunochemical determination of concentrations and molecular heterogeneity
46. Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patients
47. Reduced cholecystokinin immunoreactivity in the cerebrospinal fluid of patients with psychiatric disorders
48. Cholecystokinin and neurotensin gradients in human CSF
49. Increased cerebrospinal fluid of C- but not N-terminal cholecystokinin fragments in multiple sclerosis
50. CSF cholecystokinin concentrations in patients with panic disorder and in normal comparison subjects
51. Cholecystokinin peptides in cerebrospinal fluid: a study in healthy male subjects
52. Cholecystokinin and other neuropeptides in cerebrospinal fluid in psychiatric disorders
53. Cerebrospinal fluid cholecystokinin, bombesin and somatostatin in schizophrenia and normals
54. Patterns of prohormone processing: order revealed by a new procholecystokinin-derived peptide
55. Cholecystokinin in panic disorder
56. How to measure cholecystokinin in tissue, plasma and cerebrospinal fluid